VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 80 of Oncotarget features Figure 5, "Molecular modeling of MR30," by Rupp, et al.
Table of Contents
Research Papers: Pathology
|
| Chronic heart failure is characterized by altered mitochondrial function and structure in circulating leucocytes |
|
https://doi.org/10.18632/oncotarget.26164
|
| 35028-35040 |
Research Papers
|
| Molecular analysis of the dual targeting of the epidermal growth factor receptor and the O<sup>6</sup>methylguanineDNA methyltransferase with a double arm hybrid molecule |
|
https://doi.org/10.18632/oncotarget.25120
|
| 35041-35055 |
|
| Predictive values of two frailty screening tools in older patients with solid cancer: a comparison of SAOP2 and G8 |
|
https://doi.org/10.18632/oncotarget.26147
|
| 35056-35068 |
|
| The Cockayne syndrome protein B is involved in the repair of 5AZA2′deoxycytidineinduced DNA lesions |
|
https://doi.org/10.18632/oncotarget.26189
|
| 35069-35084 |
|
| LncRNAs as novel players in hepatocellular carcinoma recurrence |
|
https://doi.org/10.18632/oncotarget.26202
|
| 35085-35099 |
|
| IDH1<sup>R132H</sup> is intrinsically tumorsuppressive but functionally attenuated by the glutamaterich cerebral environment |
|
https://doi.org/10.18632/oncotarget.26203
|
| 35100-35113 |
|
| MicroRNA expression profile during different conditions of hypoxia |
|
https://doi.org/10.18632/oncotarget.26210
|
| 35114-35122 |
|
| CXCR4 and BCRtriggered integrin activation in Bcell chronic lymphocytic leukemia cells depends on JAK2activated Bruton's tyrosine kinase |
|
https://doi.org/10.18632/oncotarget.26212
|
| 35123-35140 |
|
| Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines |
|
https://doi.org/10.18632/oncotarget.26216
|
| 35141-35161 |
|
| Transcriptomic and genomic profiling of earlystage ovarian carcinomas associated with histotype and overall survival |
|
https://doi.org/10.18632/oncotarget.26225
|
| 35162-35180 |
Reviews
|
| Brain metastases in ALKpositive NSCLC – time to adjust current treatment algorithms |
|
https://doi.org/10.18632/oncotarget.26073
|
| 35181-35194 |
Corrections
|
| Correction: The nuclearcytoplasmic trafficking of a chromatinmodifying and remodelling protein KMT2C in osteosarcoma |
|
https://doi.org/10.18632/oncotarget.26240
|
| 35195-35195 |
Errata
|
| Erratum: Disruption of MycMax Heterodimerization with Improved CellPenetrating Analogs of the Small Molecule 10074G5 |
|
https://doi.org/10.18632/oncotarget.26241
|
| 35196-35196 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
